ChartMill assigns a fundamental rating of 3 / 10 to EMMA.
ChartMill assigns a valuation rating of 0 / 10 to Emmaus Life Sciences Inc. (EMMA). This can be considered as Overvalued.
Emmaus Life Sciences Inc. (EMMA) has a profitability rating of 0 / 10.
The Earnings per Share (EPS) of Emmaus Life Sciences Inc. (EMMA) is expected to grow by 50.09% in the next year.